Andersen, Henrik U.

The Effect of Real-Time Continuous Glucose Monitoring in Pregnant Women With Diabetes

Secher, A. L., Ringholm, L., Andersen, H. U., Damm, P., & Mathiesen, E. R. (2013) · Diabetes Care

Gestational Diabetes Research and ManagementDiabetes Management and Research

Cited by 214

Twelve-week treatment with liraglutide as add-on to insulin in normal-weight patients with poorly controlled type 1 diabetes: a randomized, placebo-controlled, double-blind parallel study

Frandsen, C. S., Dejgaard, T. F., Holst, J. J., Andersen, H. U., Thorsteinsson, B., & Madsbad, S. (2015) · Diabetes Care

Diabetes Management and ResearchDiabetes Treatment and Management

Cited by 103

Changes in basal rates and bolus calculator settings in insulin pumps during pregnancy in women with type 1 diabetes

Mathiesen, J. M., Secher, A. L., Ringholm, L., Nørgaard, K., Hommel, E., Andersen, H. U., Damm, P., & Mathiesen, E. R. (2014) · The Journal of Maternal-Fetal & Neonatal Medicine

Diabetes Management and ResearchGestational Diabetes Research and Management

Cited by 58

Hypoglycemic exposure and risk of asymptomatic hypoglycemia in type 1 diabetes assessed by continuous glucose monitoring

Henriksen, M. M., Andersen, H. U., Thorsteinsson, B., & Pedersen-Bjergaard, U. (2018) · The Journal of Clinical Endocrinology & Metabolism

Diabetes Management and ResearchDiabetes Management and Education

Cited by 57

Liraglutide changes body composition and lowers added sugar intake in overweight persons with insulin pump-treated type 1 diabetes

Schmidt, S., Frandsen, C. S., Dejgaard, T. F., Vistisen, D., Halldórsson, T., Olsen, S. F., Jensen, J. B., Madsbad, S., Andersen, H. U., & Nørgaard, K. (2022) · Diabetes, Obesity and Metabolism

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 29

Liraglutide enhances insulin secretion and prolongs the remission period in adults with newly diagnosed type 1 diabetes (the NewLira study): A randomized, double‐blind, placebo‐controlled trial

Dejgaard, T. F., Frandsen, C. S., Kielgast, U., Størling, J., Overgaard, A. J., Svane, M. S., Olsen, M. H., Thorsteinsson, B., Andersen, H. U., Krarup, T., et al. (2024) · Diabetes, Obesity and Metabolism

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 29

Cardiovascular prognostic value of echocardiography and N terminal pro B-type natriuretic peptide in type 1 diabetes: the Thousand & 1 Study

Rørth, R., Jørgensen, P. G., Andersen, H. U., Christoffersen, C., Gøtze, J. P., Køber, L., Rossing, P., & Jensen, M. T. (2020) · European Journal of Endocrinology

Cardiovascular Function and Risk FactorsDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 27

Treatment Modality–Dependent Risk of Diabetic Ketoacidosis in Patients with Type 1 Diabetes: Danish Adult Diabetes Database Study

Hoshina, S., Andersen, G. S., Jørgensen, M. E., Ridderstråle, M., Vistisen, D., & Andersen, H. U. (2018) · Diabetes Technology & Therapeutics

Diabetes Management and ResearchDiabetes Management and Education

Cited by 18

Comparison of treatment with insulin degludec and glargine U100 in patients with type 1 diabetes prone to nocturnal severe hypoglycaemia: The HypoDeg randomized, controlled, open‐label, crossover trial

Pedersen‐Bjergaard, U., Agesen, R. M., Brøsen, J. M. B., Alibegovic, A. C., Andersen, H. U., Beck‐Nielsen, H., Gustenhoff, P., Hansen, T. K., Hedetoft, C., Jensen, T. J., et al. (2022) · Diabetes, Obesity and Metabolism

Diabetes Management and ResearchDiabetes Treatment and Management

Cited by 16